国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
5期
645-647
,共3页
米索前列醇%产后出血%缩宫素
米索前列醇%產後齣血%縮宮素
미색전렬순%산후출혈%축궁소
Misoprostol%Postpartum hemorrhage%Oxytocin
目的 观察研究米索前列醇预防产妇产后出血的临床疗效.方法 将我院从2011年1月至2012年12月收治的300例顺产产妇随机均分为实验组150例(应用米索前列醇预防产妇产后出血)和对照组150例(常规缩宫素预防产后出血).的统计并对比两组孕妇产后出血量、产后血压、止血时间以及治疗效果.结果 实验组出血量[(205.3±42.7) ml]与止血时间[(8.6±3.2)h]均小于对照组[(288.7±66.3) ml,(16.3±4.1)h],且差异有统计学意义(P＜0.05)；实验组出血量＞ 500 ml只有1例,预防有效率达99.3％,个别例(双胎)疗效不显著,可以加10％的糖水,增加子宫肌性率,加10％葡萄糖酸钙10 ml辅助疗效即可.对照组出血量＞ 500 ml有12例,预防有效率为92.0％,组间比较差异有统计学意义(P＜0.05).结论 米索前列醇能有效降低产后出血发生率,安全高效.
目的 觀察研究米索前列醇預防產婦產後齣血的臨床療效.方法 將我院從2011年1月至2012年12月收治的300例順產產婦隨機均分為實驗組150例(應用米索前列醇預防產婦產後齣血)和對照組150例(常規縮宮素預防產後齣血).的統計併對比兩組孕婦產後齣血量、產後血壓、止血時間以及治療效果.結果 實驗組齣血量[(205.3±42.7) ml]與止血時間[(8.6±3.2)h]均小于對照組[(288.7±66.3) ml,(16.3±4.1)h],且差異有統計學意義(P＜0.05)；實驗組齣血量＞ 500 ml隻有1例,預防有效率達99.3％,箇彆例(雙胎)療效不顯著,可以加10％的糖水,增加子宮肌性率,加10％葡萄糖痠鈣10 ml輔助療效即可.對照組齣血量＞ 500 ml有12例,預防有效率為92.0％,組間比較差異有統計學意義(P＜0.05).結論 米索前列醇能有效降低產後齣血髮生率,安全高效.
목적 관찰연구미색전렬순예방산부산후출혈적림상료효.방법 장아원종2011년1월지2012년12월수치적300례순산산부수궤균분위실험조150례(응용미색전렬순예방산부산후출혈)화대조조150례(상규축궁소예방산후출혈).적통계병대비량조잉부산후출혈량、산후혈압、지혈시간이급치료효과.결과 실험조출혈량[(205.3±42.7) ml]여지혈시간[(8.6±3.2)h]균소우대조조[(288.7±66.3) ml,(16.3±4.1)h],차차이유통계학의의(P＜0.05)；실험조출혈량＞ 500 ml지유1례,예방유효솔체99.3％,개별례(쌍태)료효불현저,가이가10％적당수,증가자궁기성솔,가10％포도당산개10 ml보조료효즉가.대조조출혈량＞ 500 ml유12례,예방유효솔위92.0％,조간비교차이유통계학의의(P＜0.05).결론 미색전렬순능유효강저산후출혈발생솔,안전고효.
Objective To explore the clinical efficacy of misoprostol in the prevention of postpartum hemorrhage.Methods 300 puerperas who had been hospitalized during the period of January 2011 to December 2012 were randomly divided into two groups.The study group (150 patients) were received misoprostol for prevention of postpartum hemorrhage,while the control group (150 patients) received routine therapy with oxytocin.Postpartum hemorrhage volume postpartum blood pressure,and time to hemostasis,and efficacy of therapies were compared between the two groups.Results The amount of bleeding (205.3 ±42.7)ml was smaller and time to hemostasis (8.6 ± 3.2)h was shorter in the study group than in the control group,with a significant statistical difference (P＜0.05).Only one patient in the study group developed massive bleeding of 500 ml,with a effectiveness rate of prevention of 99.3％; while 12 patients occurred bleeding of 500 ml,with a effectiveness rate of 92.0％; the difference between the groups was statistically significant (P＜0.05).Conclusions Misoprostol can effectively reduce the incidence of postpartum hemorrhage,and it is safe and efficious.
